Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2012
10/17/2012CN102727858A Medical composition for treating headaches and migraine, preparation method and application thereof
10/17/2012CN102727846A Traditional Chinese medicine decoction used for treating common cold, and preparation method thereof
10/17/2012CN102727834A Traditional Chinese medicine composition for treating migraine, and preparation method and application thereof
10/17/2012CN102727823A Medicine for postoperative rehabilitation of cerebral hemorrhage
10/17/2012CN102727772A Method for raising content uniformity of vitamin C in vitamin C forsythia granules
10/17/2012CN102727760A Health product for enhancing physical strength
10/17/2012CN102727759A Curcumin-dendrobium officinale complex capable of relieving or neutralizing effect of alcohol and protecting liver, and preparation method thereof
10/17/2012CN102727741A Medicament for treating anxiety disorder
10/17/2012CN102727728A Resurgent traditional Chinese herbal preparation
10/17/2012CN102727671A Traditional Chinese medicine composition for treating diabetic neuropathy and preparation method and application thereof
10/17/2012CN102727657A Medicament for treating neurasthenia
10/17/2012CN102727652A Traditional Chinese medicine composition for enhancing memory as well as preparation method and application of Traditional Chinese medicine composition
10/17/2012CN102727647A A health care formula for foot bath
10/17/2012CN102727646A Medicine for treating insomnia
10/17/2012CN102727616A Ethyl acetate extract product of Chinese fevervine herb and root and application thereof
10/17/2012CN102727606A Traditional Chinese medicinal pain-relieving plaster
10/17/2012CN102727603A Oral preparation and its preparation method
10/17/2012CN102727587A Puffed Spica Prunellae, mulberry leaf and chrysanthemum granule, and preparation method thereof
10/17/2012CN102727570A External pharmaceutical composition for treating diabetic foot as well as preparation method and application of external pharmaceutical composition
10/17/2012CN102727548A New technology and method for extracting ginseng stem and leaf total saponin
10/17/2012CN102727546A Health-promoting composition for treating insomnia and cardiovascular/cerebrovascular diseases
10/17/2012CN102727538A Process for extracting ginkgo biloba flavone, ginkgo biloba lactone and ginkgo biloba phenolic acid from ginkgo biloba leaves
10/17/2012CN102727530A Combination and application of probiotics and related prebiotics
10/17/2012CN102727508A Preparation of panaxadiol saponins component and pharmaceutical application for prevention and treatment of Parkinson disease
10/17/2012CN102727507A Gastrodia elata parishin extract freeze-dried powder injection and preparing method therefor
10/17/2012CN102727506A Application of gastrodiaelata blume parishin extractive in preparation of medicament for protecting brain
10/17/2012CN102727501A Uses of sapogenins and their derivatives
10/17/2012CN102727499A Application of compound 6-furfurylaminopurine in preparations of anti-vascular dementia drugs
10/17/2012CN102727485A Application of Inula lineariifolia lactone A in preparation of medicine for treating multiple sclerosis
10/17/2012CN102727484A Use of silymarin in preparations of drugs for treatment of Alzheimer's disease
10/17/2012CN102727482A Daidzein-hydroxypropyl-beta-cyclodextrin clathrate and its preparation method
10/17/2012CN102727475A Application of retinoic acid and its derivatives in preparation of drugs preventing and treating Alzheimer's disease
10/17/2012CN102727474A Application of L-cysteine in preparing medicines used for relieving or neutralizing effect of alcohol and medicines for protecting liver and kidney
10/17/2012CN102727465A Nicotine-containing patch preparation
10/17/2012CN102727453A Blonanserin dispersible tablet and its preparation method
10/17/2012CN102727452A Eszopiclone-containing particle and its preparation method
10/17/2012CN102727449A Stable naloxone hydrochloride lyophilized preparation and preparation method thereof
10/17/2012CN102727428A Preparation method of muscular amino acids and nucleosides injection
10/17/2012CN102726710A Health product with sedative and soporific functions, and preparation method thereof
10/17/2012CN102311432B Stable vinpocetine compound and pharmaceutical composition thereof
10/17/2012CN102240340B Method for processing prepared rehmannia root
10/17/2012CN102210658B Microcapsule soft capsule preparation with high alpha-linolenic acid content
10/17/2012CN102188468B Preparation method of Xinnaoshutong tablet
10/17/2012CN102151268B Compound preparation for treating Alzheimer's disease and preparation method thereof
10/17/2012CN102076349B Withania somnifera plant extract and method for manufacturing thereof
10/17/2012CN102048685B Pefloxacin mesylate injection and preparation method and application thereof
10/17/2012CN101939297B Benzylpiperizine compound
10/17/2012CN101919801B Solid effervescent mixture for oral absorption
10/17/2012CN101559115B Application of traditional Chinese medicine composition in preparing medicament for curing senile dementia
10/17/2012CN101220064B Novel scutellaria glycosides compounds and uses thereof
10/17/2012CN101217949B 治疗睡眠-清醒病症 Treatment of sleep - wake disorders
10/16/2012US8288560 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
10/16/2012US8288539 Dipeptidyl peptidase inhibitors
10/16/2012US8288537 Caspase inhibitors and uses thereof
10/16/2012US8288442 Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
10/16/2012US8288420 Compounds capable of activating cholinergic receptors
10/16/2012US8288399 Medicine containing pyrimidine derivative
10/16/2012US8288378 Phosphoinositide modulation for the treatment of neurodegenerative diseases
10/16/2012US8288372 Method for treating headache with loxapine
10/16/2012US8288139 Sulfotransferase inhibitors
10/16/2012CA2601715C Dosage regimen for the treatment of a traumatic brain injury with progesterone
10/16/2012CA2554426C Agents for treating migraine
10/16/2012CA2505040C Composition for iontophoretic delivery of rotigotine
10/16/2012CA2485681C Ccr9 inhibitors and methods of use thereof
10/16/2012CA2471906C A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity
10/16/2012CA2466773C Inhibitor oligonucleotides and their use for specific repression of a gene
10/16/2012CA2456049C Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
10/16/2012CA2455271C Use of musk autoantibodies
10/16/2012CA2404340C Methods of blocking tissue destruction by autoreactive t cells
10/16/2012CA2356257C Insulin-like growth factor (igf) i mutant variants
10/11/2012WO2012139069A2 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012WO2012139043A2 Selective neuronal nitric oxide synthase inhibitors
10/11/2012WO2012138945A1 Methods of treating schizophrenia with pyrazole derivative inhibitors of tgf - beta
10/11/2012WO2012138797A1 3- or 5 - bi phenyl - 4 - ylisoxazole - based compounds useful for the treatment of fibrosis, pain, cancer and respiratory, allergic, nervous system or cardiovascular disorders
10/11/2012WO2012138599A2 Hepatocyte growth factor mimics as therapeutic agents
10/11/2012WO2012138289A1 Diagnosis and treatment of friedreich's ataxia
10/11/2012WO2012138190A2 Composition containing jetbead extracts
10/11/2012WO2012138034A1 Pharmaceutical composition for the prevention or treatment of a neurodegenerative disease, comprising a daphne genkwa extract or a compound isolated therefrom
10/11/2012WO2012137971A1 Combinations comprising brexpiprazole or a salt thereof and a second drug for use in the treatment of a cns disorder
10/11/2012WO2012137645A1 Preventive and/or therapeutic agent for allodynia caused by anticancer agent
10/11/2012WO2012137146A2 Means for concealing the flavour and smell of peptide hydrolysates
10/11/2012WO2012137089A1 Pyrrolo [2, 3 -d] pyrimidine derivatives as inhibitors of tropomyosin- related kinases
10/11/2012WO2012136772A1 Fused pyrrole derivates as estrogen receptor ligands
10/11/2012WO2012136699A1 Use of l-carnitine, salts and derivatives thereof for reducing or preventing fatigue and improving cognitive function
10/11/2012WO2012136655A1 Phenoxazinones or phenothiazones as inhibitors of amyloid formation
10/11/2012WO2012136603A1 1,4-oxazepines as bace1 and/or bace2 inhibitors
10/11/2012WO2012136587A1 Repair of neurodegenerative disease
10/11/2012WO2012136552A1 ANTIBODIES SPECIFIC TO PYROGLUTAMATED Αβ
10/11/2012WO2012136534A2 Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
10/11/2012WO2012136356A1 6,7-diydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivatives and pharmaceutical compositions containing the same as hypnotic or anesthetic agent and method for their preparation
10/11/2012WO2012136351A1 Tapentadol for treating pain associated with trigeminal neuralgia
10/11/2012WO2012136349A1 Tapentadol for preventing chronification of pain
10/11/2012WO2012136317A1 Rosmarinic acid for smoker dehabituation
10/11/2012WO2012136147A1 Benzopyrone derivative and use thereof
10/11/2012WO2012096929A3 Heteroaryl compounds and methods of use thereof
10/11/2012WO2012091449A3 Pharmaceutical composition comprising phosphorylated grasp for treating cystic fibrosis
10/11/2012US20120259151 Pyridopyrazine derivatives and their use
10/11/2012US20120259022 Pharmaceutical compositions providing enhanced drug concentrations
10/11/2012US20120259012 Treatment for Amyotrophic Lateral Sclerosis
10/11/2012US20120259006 Novel benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof
1 ... 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 ... 1833